R&D Systems™ Recombinant Rat TrkA Fc Chimera Protein

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Supplier:  R&D Systems™ 1056TK050

Catalog No. 1056TK050

Description

The Recombinant Rat TrkA Fc Chimera Protein is derived from NS0. The Recombinant Rat TrkA Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Molecular Weight (g/mol): 69 kDa (monomer)
• Quantity: 50 μg
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Conjugate: Unconjugated
• Purity or Quality Grade: 90%, by SDS-PAGE under reducing conditions and visualized by silver stain.

• Gene ID (Entrez): 59109
• Name: TrkA Fc Chimera
• Source: Mouse myeloma cell line,NS0-derived rat TrkA protein, (N-terminus) Rat TrkA (Ala33-Pro418) & (Ala34-Pro418) Accession &Num; P35739 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Structural Form: Disulfide-linked homodimer
• Recombinant: Recombinant